volume 9 issue 1 publication number 44

Major depressive disorder

Brenda W. J. H. Penninx 2
Marco Solmi 3, 4, 5
Toshi A. Furukawa 6
Joseph Firth 7, 8
Andre F. Carvalho 1
Michael Berk 1
Publication typeJournal Article
Publication date2023-08-24
scimago Q1
wos Q1
SJR17.995
CiteScore113.3
Impact factor60.6
ISSN2056676X
General Medicine
Abstract
Major depressive disorder (MDD) is characterized by persistent depressed mood, loss of interest or pleasure in previously enjoyable activities, recurrent thoughts of death, and physical and cognitive symptoms. People with MDD can have reduced quality of life owing to the disorder itself as well as related medical comorbidities, social factors, and impaired functional outcomes. MDD is a complex disorder that cannot be fully explained by any one single established biological or environmental pathway. Instead, MDD seems to be caused by a combination of genetic, environmental, psychological and biological factors. Treatment for MDD commonly involves pharmacological therapy with antidepressant medications, psychotherapy or a combination of both. In people with severe and/or treatment-resistant MDD, other biological therapies, such as electroconvulsive therapy, may also be offered. This Primer summarizes the epidemiology, mechanisms, diagnosis and treatment of major depressive disorder (MDD). This Primer also reviews how this disorder affects patient quality of life, and provides an overview of future research.
Found 
Found 

Top-30

Journals

5
10
15
20
25
30
35
40
Journal of Affective Disorders
39 publications, 9.85%
Frontiers in Psychiatry
17 publications, 4.29%
International Journal of Molecular Sciences
10 publications, 2.53%
Translational Psychiatry
8 publications, 2.02%
Scientific Reports
8 publications, 2.02%
Molecular Psychiatry
6 publications, 1.52%
BMC Psychiatry
6 publications, 1.52%
Psychiatry Research
6 publications, 1.52%
Journal of Psychiatric Research
5 publications, 1.26%
Psychological Medicine
5 publications, 1.26%
Depression and Anxiety
4 publications, 1.01%
Molecular Neurobiology
3 publications, 0.76%
Pharmaceuticals
3 publications, 0.76%
Nutrients
3 publications, 0.76%
Journal of Personalized Medicine
3 publications, 0.76%
Brain Sciences
3 publications, 0.76%
Brain, Behavior, and Immunity
3 publications, 0.76%
Advances in Experimental Medicine and Biology
3 publications, 0.76%
Frontiers in Nutrition
3 publications, 0.76%
Progress in Neuro-Psychopharmacology and Biological Psychiatry
3 publications, 0.76%
Nature Communications
3 publications, 0.76%
Frontiers in Pharmacology
3 publications, 0.76%
Psychoneuroendocrinology
2 publications, 0.51%
Cells
2 publications, 0.51%
Biomedicine and Pharmacotherapy
2 publications, 0.51%
Pharmacology Biochemistry and Behavior
2 publications, 0.51%
Frontiers in Neuroscience
2 publications, 0.51%
Communications Biology
2 publications, 0.51%
Neuropsychopharmacology
2 publications, 0.51%
5
10
15
20
25
30
35
40

Publishers

20
40
60
80
100
120
140
Elsevier
127 publications, 32.07%
Springer Nature
83 publications, 20.96%
MDPI
36 publications, 9.09%
Frontiers Media S.A.
33 publications, 8.33%
Wiley
30 publications, 7.58%
Cold Spring Harbor Laboratory
15 publications, 3.79%
Institute of Electrical and Electronics Engineers (IEEE)
11 publications, 2.78%
Taylor & Francis
11 publications, 2.78%
Cambridge University Press
7 publications, 1.77%
SAGE
5 publications, 1.26%
Ovid Technologies (Wolters Kluwer Health)
4 publications, 1.01%
Baishideng Publishing Group
3 publications, 0.76%
American Medical Association (AMA)
3 publications, 0.76%
Research Square Platform LLC
2 publications, 0.51%
American Chemical Society (ACS)
2 publications, 0.51%
IMR Press
2 publications, 0.51%
Public Library of Science (PLoS)
2 publications, 0.51%
AOSIS
2 publications, 0.51%
American Physiological Society
1 publication, 0.25%
Spandidos Publications
1 publication, 0.25%
Media Sphere Publishing House
1 publication, 0.25%
Royal Society of Chemistry (RSC)
1 publication, 0.25%
Walter de Gruyter
1 publication, 0.25%
SPIE-Intl Soc Optical Eng
1 publication, 0.25%
Oxford University Press
1 publication, 0.25%
American Association for the Advancement of Science (AAAS)
1 publication, 0.25%
Georg Thieme Verlag KG
1 publication, 0.25%
Jaypee Brothers Medical Publishing
1 publication, 0.25%
BMJ
1 publication, 0.25%
20
40
60
80
100
120
140
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
396
Share
Cite this
GOST |
Cite this
GOST Copy
Marx W. et al. Major depressive disorder // Nature Reviews Disease Primers. 2023. Vol. 9. No. 1. 44
GOST all authors (up to 50) Copy
Marx W., Penninx B. W., Solmi M., Furukawa T. A., Firth J., Carvalho A. F., Berk M. Major depressive disorder // Nature Reviews Disease Primers. 2023. Vol. 9. No. 1. 44
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1038/s41572-023-00454-1
UR - https://doi.org/10.1038/s41572-023-00454-1
TI - Major depressive disorder
T2 - Nature Reviews Disease Primers
AU - Marx, Wolfgang
AU - Penninx, Brenda W. J. H.
AU - Solmi, Marco
AU - Furukawa, Toshi A.
AU - Firth, Joseph
AU - Carvalho, Andre F.
AU - Berk, Michael
PY - 2023
DA - 2023/08/24
PB - Springer Nature
IS - 1
VL - 9
PMID - 37620370
SN - 2056-676X
ER -
BibTex
Cite this
BibTex (up to 50 authors) Copy
@article{2023_Marx,
author = {Wolfgang Marx and Brenda W. J. H. Penninx and Marco Solmi and Toshi A. Furukawa and Joseph Firth and Andre F. Carvalho and Michael Berk},
title = {Major depressive disorder},
journal = {Nature Reviews Disease Primers},
year = {2023},
volume = {9},
publisher = {Springer Nature},
month = {aug},
url = {https://doi.org/10.1038/s41572-023-00454-1},
number = {1},
pages = {44},
doi = {10.1038/s41572-023-00454-1}
}
Profiles